tiprankstipranks
Globus Medical (GMED)
NYSE:GMED
US Market
GMED
Globus Medical
RESEARCH TOOLSreports
Want to see GMED full AI Analyst Report?

Globus Medical (GMED) Stock Forecast & Price Target

1,003 Followers
See the Price Targets and Ratings of:

GMED Analyst Ratings

Strong Buy
12Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Globus
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GMED Stock 12 Month Forecast

Average Price Target

$110.90
▲(16.43% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $110.90 with a high forecast of $123.00 and a low forecast of $95.00. The average price target represents a 16.43% change from the last price of $95.25.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","124":"$124","69.25":"$69.3","87.5":"$87.5","105.75":"$105.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":123,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$123.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":110.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$110.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$95.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,69.25,87.5,105.75,124],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.34,93.77538461538462,96.21076923076923,98.64615384615385,101.08153846153846,103.51692307692308,105.9523076923077,108.3876923076923,110.82307692307693,113.25846153846155,115.69384615384615,118.12923076923077,120.5646153846154,{"y":123,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.34,92.8446153846154,94.34923076923077,95.85384615384616,97.35846153846154,98.86307692307693,100.36769230769231,101.8723076923077,103.37692307692308,104.88153846153847,106.38615384615385,107.89076923076924,109.39538461538461,{"y":110.9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.34,91.62153846153846,91.90307692307692,92.18461538461538,92.46615384615384,92.7476923076923,93.02923076923076,93.31076923076924,93.5923076923077,93.87384615384616,94.15538461538462,94.43692307692308,94.71846153846154,{"y":95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.66,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.39,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.31,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.74,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.34,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$123.00Average Price Target$110.90Lowest Price Target$95.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on GMED
Matt Miksic
Barclays
Barclays
$123
Buy
29.13%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), BridgeBio Pharma (NASDAQ: BBIO) and Globus Medical (NYSE: GMED)
Truist Financial Analyst forecast on GMED
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/08/26
Analysts' Top Healthcare Picks: Maravai Lifesciences Holdings (MRVI), Globus Medical (GMED)
TD Cowen Analyst forecast on GMED
Mathew Blackman
TD Cowen
TD Cowen
$112→$115
Buy
20.73%
Upside
Reiterated
05/08/26
Mathew Blackman Reiterates Buy on Globus Medical, Lifts Price Target to $115 on Durable Growth and Profitability Outlook
Canaccord Genuity Analyst forecast on GMED
Caitlin Cronin
Canaccord Genuity
Canaccord Genuity
$115
Buy
20.73%
Upside
Reiterated
05/08/26
Canaccord Genuity Sticks to Their Buy Rating for Globus Medical (GMED)
Stifel Nicolaus Analyst forecast on GMED
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$95
Hold
-0.26%
Downside
Reiterated
05/08/26
Stifel Nicolaus Reaffirms Their Hold Rating on Globus Medical (GMED)
Wells Fargo Analyst forecast on GMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$104→$103
Buy
8.14%
Upside
Reiterated
05/08/26
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Needham Analyst forecast on GMED
David Saxon
Needham
Needham
$114→$117
Buy
22.83%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on GMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$115
Buy
20.73%
Upside
Reiterated
05/08/26
Piper Sandler Sticks to Their Buy Rating for Globus Medical (GMED)
RBC Capital Analyst forecast on GMED
Shagun Singh Chadha
RBC Capital
RBC Capital
$115→$120
Buy
25.98%
Upside
Reiterated
05/07/26
RBC Capital Remains a Buy on Globus Medical (GMED)
BTIG Analyst forecast on GMED
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
02/25/26
Globus Medical (GMED) Receives a Hold from BTIG
Bank of America Securities Analyst forecast on GMED
Travis Steed
Bank of America Securities
Bank of America Securities
$106
Buy
11.29%
Upside
Reiterated
02/25/26
Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)
Morgan Stanley Analyst forecast on GMED
Patrick Wood
Morgan Stanley
Morgan Stanley
$100
Buy
4.99%
Upside
Reiterated
02/25/26
Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating
Jefferies Analyst forecast on GMED
Matthew Taylor
Jefferies
Jefferies
$105→$115
Buy
20.73%
Upside
Reiterated
01/08/26
Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)
Freedom Capital Markets Analyst forecast on GMED
Keith Hinton
Freedom Capital Markets
Freedom Capital Markets
$87
Hold
-8.66%
Downside
Initiated
12/16/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)
Citizens JMP Analyst forecast on GMED
David Turkaly
Citizens JMP
Citizens JMP
―
Hold
―
Reiterated
08/20/25
Citizens JMP Remains a Hold on Globus Medical (GMED)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on GMED
Matt Miksic
Barclays
Barclays
$123
Buy
29.13%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), BridgeBio Pharma (NASDAQ: BBIO) and Globus Medical (NYSE: GMED)
Truist Financial Analyst forecast on GMED
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/08/26
Analysts' Top Healthcare Picks: Maravai Lifesciences Holdings (MRVI), Globus Medical (GMED)
TD Cowen Analyst forecast on GMED
Mathew Blackman
TD Cowen
TD Cowen
$112→$115
Buy
20.73%
Upside
Reiterated
05/08/26
Mathew Blackman Reiterates Buy on Globus Medical, Lifts Price Target to $115 on Durable Growth and Profitability Outlook
Canaccord Genuity Analyst forecast on GMED
Caitlin Cronin
Canaccord Genuity
Canaccord Genuity
$115
Buy
20.73%
Upside
Reiterated
05/08/26
Canaccord Genuity Sticks to Their Buy Rating for Globus Medical (GMED)
Stifel Nicolaus Analyst forecast on GMED
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
$95
Hold
-0.26%
Downside
Reiterated
05/08/26
Stifel Nicolaus Reaffirms Their Hold Rating on Globus Medical (GMED)
Wells Fargo Analyst forecast on GMED
Larry Biegelsen
Wells Fargo
Wells Fargo
$104→$103
Buy
8.14%
Upside
Reiterated
05/08/26
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Needham Analyst forecast on GMED
David Saxon
Needham
Needham
$114→$117
Buy
22.83%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on GMED
Matthew O'Brien
Piper Sandler
Piper Sandler
$115
Buy
20.73%
Upside
Reiterated
05/08/26
Piper Sandler Sticks to Their Buy Rating for Globus Medical (GMED)
RBC Capital Analyst forecast on GMED
Shagun Singh Chadha
RBC Capital
RBC Capital
$115→$120
Buy
25.98%
Upside
Reiterated
05/07/26
RBC Capital Remains a Buy on Globus Medical (GMED)
BTIG Analyst forecast on GMED
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
02/25/26
Globus Medical (GMED) Receives a Hold from BTIG
Bank of America Securities Analyst forecast on GMED
Travis Steed
Bank of America Securities
Bank of America Securities
$106
Buy
11.29%
Upside
Reiterated
02/25/26
Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)
Morgan Stanley Analyst forecast on GMED
Patrick Wood
Morgan Stanley
Morgan Stanley
$100
Buy
4.99%
Upside
Reiterated
02/25/26
Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating
Jefferies Analyst forecast on GMED
Matthew Taylor
Jefferies
Jefferies
$105→$115
Buy
20.73%
Upside
Reiterated
01/08/26
Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)
Freedom Capital Markets Analyst forecast on GMED
Keith Hinton
Freedom Capital Markets
Freedom Capital Markets
$87
Hold
-8.66%
Downside
Initiated
12/16/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)
Citizens JMP Analyst forecast on GMED
David Turkaly
Citizens JMP
Citizens JMP
―
Hold
―
Reiterated
08/20/25
Citizens JMP Remains a Hold on Globus Medical (GMED)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

3 Months
Jason WittesRoth MKM
Success Rate
15/23 ratings generated profit
65%
Average Return
+4.55%
Copying Jason Wittes's trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +4.55% per trade.
1 Year
Caitlin CroninCanaccord Genuity
Success Rate
8/13 ratings generated profit
62%
Average Return
+14.96%
Copying Caitlin Cronin's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +14.96% per trade.
2 Years
Matt MiksicBarclays
Success Rate
23/32 ratings generated profit
72%
Average Return
+20.14%
Copying Matt Miksic's trades and holding each position for 2 Years would result in 71.88% of your transactions generating a profit, with an average return of +20.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMED Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
2
Buy
27
27
24
13
9
Hold
8
8
6
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
35
30
15
12
In the current month, GMED has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 110.90.
Each month's total comprises the sum of three months' worth of ratings.

GMED Financial Forecast

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is $1.10 with a range of $1.05 to $1.14. The previous quarter’s EPS was $1.12. GMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.
Next quarter’s earnings estimate for GMED is $1.10 with a range of $1.05 to $1.14. The previous quarter’s EPS was $1.12. GMED beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Sales Forecast

Next quarter’s sales forecast for GMED is $783.82M with a range of $773.70M to $795.75M. The previous quarter’s sales results were $759.85M. GMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.
Next quarter’s sales forecast for GMED is $783.82M with a range of $773.70M to $795.75M. The previous quarter’s sales results were $759.85M. GMED beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year GMED has Performed in-line its overall industry.

GMED Stock Forecast FAQ

What is GMED’s average 12-month price target, according to analysts?
Based on analyst ratings, Globus Medical’s 12-month average price target is 110.90.
    What is GMED’s upside potential, based on the analysts’ average price target?
    Globus Medical has 16.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GMED a Buy, Sell or Hold?
          Globus Medical has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Globus Medical’s price target?
            The average price target for Globus Medical is 110.90. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $123.00 ,the lowest forecast is $95.00. The average price target represents 16.43% Increase from the current price of $95.25.
              What do analysts say about Globus Medical?
              Globus Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of GMED?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.